Citigroup
OPK icon

Citigroup’s Opko Health OPK Stock Holding History

Citigroup’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-138,000
Closed -$545K – 7082
2020
Q4 		$545K Buy
138,000
+54,200
+65% +$226K ﹤0.01% 4129
2020
Q3 		$309K Buy
83,800
+46,700
+126% +$197K ﹤0.01% 4258
2020
Q2 		$127K Sell
37,100
-3,500
-9% -$7.84K ﹤0.01% 5378
2020
Q1 		$54K Sell
40,600
-29,000
-42% -$45.4K ﹤0.01% 5919
2019
Q4 		$102K Buy
69,600
+6,300
+10% +$10.5K ﹤0.01% 5759
2019
Q3 		$132K Sell
63,300
-23,600
-27% -$48.2K ﹤0.01% 5475
2019
Q2 		$212K Sell
86,900
-11,900
-12% -$26K ﹤0.01% 5214
2019
Q1 		$258K Sell
98,800
-95,700
-49% -$290K ﹤0.01% 4852
2018
Q4 		$585K Buy
194,500
+14,600
+8% +$49.5K ﹤0.01% 3961
2018
Q3 		$622K Buy
179,900
+95,300
+113% +$506K ﹤0.01% 4016
2018
Q2 		$398K Buy
84,600
+9,500
+13% +$36K ﹤0.01% 4345
2018
Q1 		$238K Sell
75,100
-37,600
-33% -$151K ﹤0.01% 4791
2017
Q4 		$552K Buy
112,700
+36,000
+47% +$209K ﹤0.01% 3998
2017
Q3 		$526K Buy
76,700
+28,200
+58% +$178K ﹤0.01% 4069
2017
Q2 		$319K Buy
48,500
+4,700
+11% +$32.9K ﹤0.01% 4395
2017
Q1 		$350K Buy
43,800
+3,600
+9% +$30.3K ﹤0.01% 4167
2016
Q4 		$374K Buy
40,200
+5,700
+17% +$59K ﹤0.01% 4683
2016
Q3 		$365K Sell
34,500
-3,500
-9% -$34.9K ﹤0.01% 4179
2016
Q2 		$355K Sell
38,000
-5,700
-13% -$57.9K ﹤0.01% 3989
2016
Q1 		$454K Buy
43,700
+25,000
+134% +$228K ﹤0.01% 4230
2015
Q4 		$188K Buy
18,700
+11,900
+175% +$119K ﹤0.01% 4804
2015
Q3 		$57K Buy
+6,800
New +$90K ﹤0.01% 5349
2015
Q1 		– Sell
-100,000
Closed -$999K – 7358
2014
Q4 		$999K Hold
100,000
– – ﹤0.01% 3139
2014
Q3 		$851K Buy
+100,000
New +$879K ﹤0.01% 3123

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citigroup's OPK Position: Q2 2026 in Review

Citigroup increased its Opko Health (OPK) stake by 493% in Q2 2026, buying an estimated $212K and bringing the position to 199,824 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #4132.

Citigroup first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.41M in Q4 2018. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Citigroup held 199,824 shares of Opko Health worth $300K as of Q2 2026.
  • Citigroup bought 166,148 Opko Health shares in Q2 2026, an estimated $212K.
  • Opko Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4132 holding.
  • Citigroup first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Opko Health position peaked at $6.41M in Q4 2018.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.